In total, 44 abstracts (including four late-breakers) will be presented by Novartis, representing more than any other company at the congress.Novartis is committed to making a difference to the lives of millions of people worldwide living with debilitating conditions, such as COPD and severe asthma, said Vasant Narasimhan, Global Head of Development, Novartis Pharmaceuticals.